Suchergebnisse - "Beaty, Laurel E"

PubPharm (18)

1

Real World Evidence of Neutralizing Monoclonal Antibodies for Preventing Hospitalization and Mortality in COVID-19 Outpatients

enthalten in: bioRxiv.org | 2024

von Wynia, M. | Beaty, L. | Bennett, T. | +12

2

Change in Effectiveness of Sotrovimab for Preventing Hospitalization and Mortality in COVID-19 Outpatients During the Omicron Phase

enthalten in: bioRxiv.org | 2024

von Aggarwal, N. | Beaty, L. | Bennett, T. | +2

3

Association between monoclonal antibody therapy, vaccination, and longer-term symptom resolution after acute COVID-19

enthalten in: Journal of medical virology | 2024

von Roberts, S. | Jolley, S. | Beaty, L. | +9

4

Real-world use of nirmatrelvir-ritonavir in COVID-19 outpatients during BQ.1, BQ.1.1., and XBB.1.5 predominant omicron variants in three U.S. health systems : a retrospective cohort study

enthalten in: Lancet regional health. Americas | 2024

von Aggarwal, N. | Beaty, L. | Bennett, T. | +13

5

Association between monoclonal antibody therapy, vaccination, and longer‐term symptom resolution after acute COVID‐19

enthalten in: Journal of Medical Virology | 2024

von Roberts, S. | Jolley, S. | Beaty, L. | +9

6

Real World Evidence of the Neutralizing Monoclonal Antibody Sotrovimab for Preventing Hospitalization and Mortality in COVID-19 Outpatients

enthalten in: bioRxiv.org | 2023

von Aggarwal, N. | Beaty, L. | Bennett, T. | +11

7

Real-world evaluation of bebtelovimab effectiveness during the period of COVID-19 Omicron variants, including BA.4/BA.5

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2023

von Molina, K. | Kennerley, V. | Beaty, L. | +8

8

Real-world use of nirmatrelvir-ritonavir in outpatients with COVID-19 during the era of omicron variants including BA.4 and BA.5 in Colorado, USA : a retrospective cohort study

enthalten in: The Lancet. Infectious diseases | 2023

von Aggarwal, N. | Molina, K. | Beaty, L. | +7

CommentIn: Lancet Infect Dis. 2023 Jun;23(6):639-640. - PMID 36780911

9

Real-World Evidence of Neutralizing Monoclonal Antibodies for Preventing Hospitalization and Mortality in COVID-19 Outpatients

enthalten in: Chest | 2023

von Wynia, M. | Beaty, L. | Bennett, T. | +12

10

Change in effectiveness of sotrovimab for preventing hospitalization and mortality for at-risk COVID-19 outpatients during an Omicron BA.1 and BA.1.1-predominant phase

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2023

von Aggarwal, N. | Beaty, L. | Bennett, T. | +7